NEPHROS, INC. Deferred Tax Assets, Capital Loss Carryforwards
NEPHROS, INC. (NEPH) had Deferred Tax Assets, Capital Loss Carryforwards of $2.04 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Capital Loss Carryforwards $2.04M.
- 2024-12-31: Deferred Tax Assets, Capital Loss Carryforwards $2.09M.
- 2023-12-31: Deferred Tax Assets, Capital Loss Carryforwards $2.07M.
- 2022-12-31: Deferred Tax Assets, Capital Loss Carryforwards $1.95M.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards |
|---|---|
| 2025-12-31 | $2.04M 10-K · filed 2026-03-12 |
| 2024-12-31 | $2.09M 10-K · filed 2026-03-12 |
| 2023-12-31 | $2.07M 10-K · filed 2025-03-24 |
| 2022-12-31 | $1.95M 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |